EUVIMEDDescoperă EUVIMED
Open access · CC BY-NC 4.0

An Integrated Network of Classical Endocrine and Retinoic Acid Pathways Reveals Points of Convergence and Knowledge Gaps

Tommaso Giorgi iD, Sophie E Paulsen iD, Muhammad Arslan Aslam iD, Marie L Holmer, Hanna K L Johansson iD, Anna Beronius iD, Terje Svingen iD

Basic & Clinical Pharmacology & Toxicology · 2026-12 · 139 (6)

DOI: 10.1111/bcpt.70331 ↗

At a glance

Journal article in Basic & Clinical Pharmacology & Toxicology, published online on 2026-11-13. Written by Tommaso Giorgi and 6 co-authors. Institution: National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark. Major MEDLINE topics: Endocrine Disruptors, Tretinoin, Signal Transduction, Adverse Outcome Pathways. 38 references. The full text is freely available (open access, CC BY-NC 4.0).

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Adverse outcome pathways (AOPs) are pragmatic descriptions of how molecular perturbations can lead to adverse effects in intact organisms. To examine connectivity across endocrine signalling pathways, we integrated 117 AOPs related to oestrogen, androgen, steroidogenesis, thyroid and retinoic acid (EATS,R) modalities into a unified endocrine AOP network (AOPN). The resulting network revealed uneven pathway representation, limited mechanistic integration across EATS,R modalities and substantial gaps in certain signalling coverage, with only six retinoic acid‐related AOPs available for integration. At the same time, the AOPN identified highly connected biological nodes linking multiple pathways to adverse outcomes, highlighting potential points of endocrine crosstalk as well as cross‐species key events (KEs), bridging human and environmental health. To strengthen retinoid pathway integration, new KEs describing altered retinoic acid receptor activation were developed as potential network hubs (KE 2419 and KE 2420). Collectively, these findings demonstrate how the AOPN reveals emergent biological relationships, exposes knowledge gaps and identifies candidate targets for NAM development, providing a framework that could be used to prioritise future AOP development, and overall, to support a more integrated, system‐level approach to endocrine disruptor identification.

Subjects

MeSH terms (MEDLINE)

Endocrine DisruptorsTretinoinSignal TransductionAdverse Outcome PathwaysEndocrine SystemHumansAnimalsReceptors, Retinoic Acid

Author keywords

EATSadverse outcome pathway (AOP)new approach methodologies (NAMs)risk assessment

Substances

Endocrine DisruptorsTretinoinReceptors, Retinoic Acid

Authors and institutions

  • National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

ORCID profiles: Tommaso Giorgi, Sophie E Paulsen, Muhammad Arslan Aslam, Hanna K L Johansson, Anna Beronius, Terje Svingen

Cite

APA

Giorgi, T., Paulsen, S. E., Aslam, M. A., Holmer, M. L., Johansson, H. K. L., Beronius, A., & Svingen, T. (2026). An Integrated Network of Classical Endocrine and Retinoic Acid Pathways Reveals Points of Convergence and Knowledge Gaps. Basic & Clinical Pharmacology & Toxicology, 139(6). https://doi.org/10.1111/bcpt.70331

Vancouver

Giorgi T, Paulsen SE, Aslam MA, Holmer ML, Johansson HKL, Beronius A, et al. An Integrated Network of Classical Endocrine and Retinoic Acid Pathways Reveals Points of Convergence and Knowledge Gaps. Basic & Clinical Pharmacology & Toxicology. 2026;139(6). doi:10.1111/bcpt.70331

BibTeX
@article{Giorgi2026,
  author = {Giorgi, Tommaso and Paulsen, Sophie E and Aslam, Muhammad Arslan and Holmer, Marie L and Johansson, Hanna K L and Beronius, Anna and Svingen, Terje},
  title = {An Integrated Network of Classical Endocrine and Retinoic Acid Pathways Reveals Points of Convergence and Knowledge Gaps},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2026},
  volume = {139},
  number = {6},
  doi = {10.1111/bcpt.70331}
}
Start for free →